Klinar has been conducted its oncology studies in the below indications:
- Breast Cancer
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
- Rectal Cancer
- Prostate Cancer
- Solid Tumors
- Renal Cell Carcinoma
- Gastroenteropancreatic Neuroendocrin Tumors
- Leukemia
- Graft Versus Host Disease
- Brain Cancer
- Gastrointestinal Stromal Tumors
- Colorectal Cancer
- Hepatocellular Carcinoma
- Ovarian Cancer
- Pancreatic Cancer
- Melanoma
- Metastatic Breast Cancer
- Gastric Cancer
- Lymphoma
- Myelodysplastic Syndrome
- Hepatoblastoma
- Adjuvant Therapy for Melanoma
- Fianlimab (ANTI-LAG-3) and Cemiplimab
- Metastatic Urothelial Cancer
- Biliary Tract Cancers
- Hepatocellular Carcinoma
- Node-positive breast cancer
- HER2 Metastatik Meme Kanseri